background preloader

SARS-COV-2 Govt Site

Facebook Twitter

CIDRAP. Homeland Security Digital Library. New CDC report shows 94% of COVID-19 deaths in US had contributing conditions. Covid 19 faqs hospitals hospital laboratory acute care facility data reporting. Leaked Pentagon memo warns of 'real possibility' of COVID-19 resurgence, vaccine not coming until summer 2021. The Defense Department should prepare to operate in a "globally-persistent" novel coronavirus (COVID-19) environment without an effective vaccine until "at least the summer of 2021," according to a draft Pentagon memo obtained by Task & Purpose.

Leaked Pentagon memo warns of 'real possibility' of COVID-19 resurgence, vaccine not coming until summer 2021

"We have a long path ahead, with the real possibility of a resurgence of COVID-19," reads the memo, authored for Secretary of Defense Mark Esper but not yet bearing his signature. "Therefore, we must now re-focus our attention on resuming critical missions, increasing levels of activity, and making necessary preparations should a significant resurgence of COVID-19 occur later this year. " Despite its grim forecast, the draft document lays out a framework for the U.S. military's proverbial reopening, which includes the resumption of training exercises, increased operational tempo, and the repositioning of forces and supplies to fight the global pandemic. A Pentagon spokeswoman said the document was outdated but declined to provide more specifics. CDC Business Plans. Infection Protection - WHO. Colorado COVID-19 Updates. Data is updated daily by about 4 p.m. and includes cases reported through the previous day.

Colorado COVID-19 Updates

This reporting gap gives our epidemiologists time to review the data and improve the accuracy. Due to this delay, our numbers may be different than what is being reported by local public health departments. As cases continue to be investigated the data in this report is subject to change. Colorado Case Summary (Updated 3/30/20 at 4:00 p.m.) Note: This summary only includes data through 3/29 and does not reflect cases since then. 2,627 cases* 414 hospitalized 47 counties 15,364 people tested 51 deaths 14 outbreaks at residential and non-hospital health care facilities *The number of cases includes people who have had a test that indicated they were positive for COVID-19. Due to high traffic, it may take a little longer to load. Find Colorado COVID-19 Data on CDPHE's Open Data Portal Access the case summary data files.

Coronavirus Update (Live): 803,466 Cases and 39,038 Deaths from COVID-19 Virus Outbreak - Worldometer. How dangerous is the virus?

Coronavirus Update (Live): 803,466 Cases and 39,038 Deaths from COVID-19 Virus Outbreak - Worldometer

There are three parameters to understand in order to assess the magnitude of the risk posed by this novel coronavirus: Transmission Rate (Ro) - number of newly infected people from a single caseCase Fatality Rate (CFR) - percent of cases that result in death Determine whether asymptomatic transmission is possible How contagious is the Wuhan Coronavirus? (Ro) The attack rate or transmissibility (how rapidly the disease spreads) of a virus is indicated by its reproductive number (Ro, pronounced R-nought or r-zero), which represents the average number of people to which a single infected person will transmit the virus. WHO's estimated (on Jan. 23) Ro to be between 1.4 and 2.5. [13] Other studies have estimated a Ro between 3.6 and 4.0, and between 2.24 to 3.58. [23]. Preliminary studies had estimated Ro to be between 1.5 and 3.5. [5][6][7] Coronavirus Disease 2019 (COVID-19) WHO launches global megatrial of the four most promising coronavirus treatments.

A drug combo already used against HIV.

WHO launches global megatrial of the four most promising coronavirus treatments

A malaria treatment first tested during World War II. A new antiviral whose promise against Ebola fizzled last year. Could any of these drugs hold the key to saving coronavirus disease 2019 (COVID-19) patients from serious harm or death? On Friday, the World Health Organization (WHO) announced a large global trial, called SOLIDARITY, to find out whether any can treat infections with the new coronavirus for the dangerous respiratory disease. It’s an unprecedented effort—an all-out, coordinated push to collect robust scientific data rapidly during a pandemic. With about 15% of COVID-19 patients suffering from severe disease and hospitals being overwhelmed, treatments are desperately needed.

Related Enrolling subjects in SOLIDARITY will be easy. “After that, no more measurements or documentation are required,” says Ana Maria Henao Restrepo, a medical officer at WHO’s Department of Immunization Vaccines and Biologicals. Remdesivir Ritonavir/lopinavir. SARS-associated Coronavirus Transmission, United States.